The retirement of director Ronald Taylor and appointment of Carol Burt as the new Lead Director signals a shift in board leadership and governance.
Filing excerpt
On August 13, 2026, Ronald Taylor, a director of Resmed, informed the Board that he will not stand for election at Resmed’s 2026 annual meeting of stockholders (the “Annual Meeting”) and intends to retire from the Board, effective at the Annual Meeting, which is expected to be held on November 18, 2026.
What this signalsFilings often name leadership changes, deals and spending plans.
Vendors
sec-8kboardChangeGet every 8-K signal for ResMed and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at ResMed this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/c81aad91-1e8f-4af4-a813-a112954742c7 returns this record as JSON. POST /v1/companies/enrich returns every signal for resmed.com.
{
"signal_id": "c81aad91-1e8f-4af4-a813-a112954742c7",
"signal_type": "sec-8k",
"signal_subtype": "boardChange",
"detected_at": "2026-08-18T07:06:16.207+00:00",
"company": {
"name": "ResMed",
"domain": "resmed.com"
},
"data": {
"detail": "The retirement of director Ronald Taylor and appointment of Carol Burt as the new Lead Director signals a shift in board leadership and governance. This change, concurrent with a switch in auditors from KPMG to PwC, indicates the company is actively reviewing key strategic partnerships and could be receptive to new vendors and strategic initiatives.",
"metrics": {
"timeframe": "next_quarter"
},
"summary": "ResMed appoints Carol Burt as new Lead Director, effective November 15, 2026, following director retirement.",
"excerpts": "On August 13, 2026, Ronald Taylor, a director of Resmed, informed the Board that he will not stand for election at Resmed’s 2026 annual meeting of stockholders (the “Annual Meeting”) and intends to retire from the Board, effective at the Annual Meeting, which is expected to be held on November 18, 2026.",
"relevance": 0.85,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/943819/000119312526354154/d292919d8k.htm",
"filing_date": "2026-08-17",
"filing_year": 2026,
"sales_relevance": "Strategic direction shift",
"signal_category": "leadership",
"vendors_mentioned": [
"KPMG LLP",
"PricewaterhouseCoopers LLP"
]
}
}
curl https://signals.autobound.ai/v1/signals/c81aad91-1e8f-4af4-a813-a112954742c7 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"resmed.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.